How to Profit from Biotech in Eastern Europe
Aug 25th, 2008 | By Sara Nunnally | Category: International InvestingIt wasn’t long ago that we published several articles urging investors into the neglected biotech industry. Now Sara Nunnally over at Taipan Publishing says Central and Eastern Europe is a hot region for the sector right now. Big pharma is also looking to enter the rapidly growing market for generic drugs. And a popular way to establish a foothold in the region is through acquisitions of local firms.